Clinical Trial Update: Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU [Phase 3]

View source ↗

Summary

A Phase 3 trial update reports completion of a study evaluating combined Cerebrolysin and Amantadine Sulfate for traumatic brain injury in ICU patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Cerebrolysin
• amantadine sulfate (amantadine sulfate)

Snippet

Sponsor: Ain Shams University | Conditions: Traumatic Brain Injury | Phase 3 | Status: COMPLETED